Literature DB >> 22454882

The effect of different nebulizers with and without intermittent positive pressure breathing on the absorption and metabolism of salbutamol.

G M Shenfield1, M E Evans, J W Paterson.   

Abstract

1 The absorption and metabolism of [(3)H]-salbutamol have been studied to assess whether intermittent positive pressure breathing (IPPB) or a particular nebulizer have any advantages in delivering bronchodilator drugs to asthmatic patients. 2 [(3)H]-salbutamol (10 mg) was given to asthmatic patients from either the Bird Mark 7 ventilator without intermittent positive pressure, the Bird micronebulizer attached to an electric air compressor, or the Wright's nebulizer attached to the same compressor. 3 All patients showed a high early plasma level of radioactivity due mainly to free salbutamol. This pattern suggests absorption from the lung and is similar to that seen after giving the drug from the Bird nebulizer using IPPB. 4 In all cases less than 20% of the original dose was absorbed by the patient. 5 Improvement in forced expiratory volume in one second (FEV(1)) was seen with all three treatments.

Entities:  

Year:  1974        PMID: 22454882      PMCID: PMC1402431          DOI: 10.1111/j.1365-2125.1974.tb00256.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  ISOPRENALINE IN THE TREATMENT OF CHRONIC BRONCHITIS; A CONTROLLED TRIAL OF DIFFERENT METHODS OF ADMINISTRATION.

Authors:  L FEINMANN; D J NEWELL
Journal:  Br J Dis Chest       Date:  1963-07

2.  COMPARATIVE EFFECTS OF ISOPROTERENOL AEROSOLS ON AIRWAY RESISTANCE IN OBSTRUCTIVE PULMONARY DISEASES.

Authors:  A A COHEN; F C HALE
Journal:  Am J Med Sci       Date:  1965-03       Impact factor: 2.378

3.  The effect of a nebulized bronchodilator administered with or without intermittent positive pressure breathing on ventilatory function in children with cystic fibrosis and asthma.

Authors:  N Chang; H Levison
Journal:  Am Rev Respir Dis       Date:  1972-12

4.  Isoprenaline resistance and the use of pressurised aerosols in asthma.

Authors:  J W Paterson; M E Conolly; D S Davies; C T Dollery
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

5.  The clinical pharmacology of oral and inhaled salbutamol.

Authors:  S R Walker; M E Evans; A J Richards; J W Paterson
Journal:  Clin Pharmacol Ther       Date:  1972 Nov-Dec       Impact factor: 6.875

6.  Pharmacokinetics of inhaled salbutamol in asthmatic patients.

Authors:  M E Evans; J W Paterson; A J Richards; S R Walker
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

7.  Proceedings: A technique for studying drug absorption from the lung in man.

Authors:  M E Evans; J W Paterson; G M Shenfield
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

8.  The metabolism of salbutamol in man.

Authors:  M E Evans; S R Walker; R T Brittain; J W Paterson
Journal:  Xenobiotica       Date:  1973-02       Impact factor: 1.908

9.  The fate of nebulized salbutamol (albuterol) administered by intermittent positive pressure respiration to asthmatic patients.

Authors:  G M Shenfield; M E Evans; S R Walker; J W Paterson
Journal:  Am Rev Respir Dis       Date:  1973-09

10.  Response of asthmatics to isoprenaline and salbutamol aerosols administered by intermittent positive-pressure ventilation.

Authors:  Y F Choo-Kang; S S Parker; I W Grant
Journal:  Br Med J       Date:  1970-11-21
View more
  4 in total

Review 1.  Assessment of drug disposition in the lung.

Authors:  A S Rebuck; A C Braude
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

2.  A population analysis of nebulized (R)-albuterol in dogs using a novel mixed gut-lung absorption PK-PD model.

Authors:  B Auclair; I W Wainer; K Fried; P Koch; T P Jerussi; M P Ducharme
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

Review 3.  Combination bronchodilator therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of beta-agonists.

Authors:  D J Morgan
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.